KEGG   DRUG: Belagenpumatucel-LHelp
Entry
D06563                      Drug                                   

Name
Belagenpumatucel-L (USAN);
Lucanix (TN)
Efficacy
Antineoplastic
Comment
Allogeneic vaccine cocktail of TGF-beta blocked, whole non-small cell lung cancer tumor cells.
Cell therapy treatment of non-small cell lung cancer
Target
TGFB2 [HSA:7042] [KO:K13376]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04350  TGF-beta signaling pathway
hsa05200  Pathways in cancer
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokines
   Transforming growth factors (RSTK-binding)
    TGFB2
     D06563  Belagenpumatucel-L (USAN)
BRITE hierarchy
Other DBs
PubChem: 47208219

» Japanese version   » Back

DBGET integrated database retrieval system